Ligand validation:6HL3

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 6HL3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HL3_NAD_B_503	63%	67%	0.16	0.955	0.57	0.71	-	2	5	0	100%	1
6HL3_NAD_D_503	60%	67%	0.159	0.945	0.58	0.7	-	2	5	0	100%	1
9FE0_NAD_D_503	88%	62%	0.096	0.972	0.69	0.77	1	2	3	0	100%	1
6HLA_NAD_B_503	87%	63%	0.098	0.971	0.62	0.78	-	2	4	0	100%	1
6HLM_NAD_D_503	69%	63%	0.123	0.936	0.65	0.76	-	1	3	0	100%	1
9FIL_NAD_D_503	62%	58%	0.123	0.959	0.7	0.9	-	2	0	0	75%	0.75
6HLI_NAD_B_502	27%	58%	0.255	0.903	0.65	0.94	-	2	6	0	100%	0.7045
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	10%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.